Nandabalan Krishnan

Director, 10% owner at BTAI

Sold, on record
$17.9M
Dollars the filings state
Form 4 sales
4
Latest Apr 6, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BTAIBioXcel Therapeutics, Inc.Director, 10% owner

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BTAIPlan not stated
    Jun 25, 2021 2021

    Sold 473,250 shares at $30.83 ($14.6M)

    Nandabalan Krishnan, Director

    Sold 5.2% of holdings ($278M position)8.5M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BTAIUnusual
    Nov 11, 2022 +504 days

    Sold 60,000 shares at $15.00 ($900k)

    Nandabalan Krishnan, Director, 10% owner

    Sold 100% of holdings ($900k position)0 shares leftFiling

  3. 3 Form 4 sale BTAIUnusual
    Jan 5, 2023 +55 days

    Sold 60,000 shares at $22.01 ($1.3M)

    Nandabalan Krishnan, Director, 10% owner

    Sold 100% of holdings ($1.3M position)0 shares leftFiling

  4. 4 Form 4 sale BTAIRoutine
    Apr 6, 2023 +91 days

    Sold 60,000 shares at $17.32 ($1M)

    Nandabalan Krishnan, Director, 10% owner

    10b5-1 planSold 100% of holdings ($1M position)0 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Nandabalan Krishnan
Source
Apr 6, 2023Apr 10, 2023BTAIDirector, 10% ownerForm 4 sale60,000$1M100.0%RoutineSEC
Jan 5, 2023Jan 6, 2023BTAIDirector, 10% ownerForm 4 sale60,000$1.3M100.0%UnusualSEC
Nov 11, 2022Nov 14, 2022BTAIDirector, 10% ownerForm 4 sale60,000$900k100.0%UnusualSEC
Jun 25, 2021Jun 29, 2021BTAIDirectorForm 4 sale473,250$14.6M5.2%Plan not statedSEC